Shares of Dolby Laboratories (NYSE:DLB – Get Free Report) have earned an average recommendation of “Moderate Buy” from the six brokerages that are covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $92.00.
DLB has been the topic of several recent research reports. Barrington Research reduced their price target on Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 19th. Robert W. Baird started coverage on Dolby Laboratories in a research report on Friday, September 5th. They set a “neutral” rating and a $74.00 target price for the company. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday. Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a report on Friday, September 5th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday, December 15th.
Read Our Latest Analysis on DLB
Insiders Place Their Bets
Institutional Investors Weigh In On Dolby Laboratories
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Allworth Financial LP grew its holdings in shares of Dolby Laboratories by 99.6% in the 3rd quarter. Allworth Financial LP now owns 1,006 shares of the electronics maker’s stock valued at $73,000 after acquiring an additional 502 shares in the last quarter. Swiss Life Asset Management Ltd bought a new position in Dolby Laboratories in the third quarter valued at approximately $210,000. Advisory Services Network LLC acquired a new position in shares of Dolby Laboratories during the 3rd quarter worth approximately $102,000. XTX Topco Ltd bought a new stake in shares of Dolby Laboratories during the 3rd quarter worth approximately $741,000. Finally, Verition Fund Management LLC grew its stake in shares of Dolby Laboratories by 172.4% in the third quarter. Verition Fund Management LLC now owns 35,409 shares of the electronics maker’s stock valued at $2,563,000 after buying an additional 22,409 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors and hedge funds.
Dolby Laboratories Price Performance
DLB stock opened at $66.26 on Monday. The company has a 50 day moving average price of $66.78 and a 200 day moving average price of $71.11. Dolby Laboratories has a fifty-two week low of $64.02 and a fifty-two week high of $89.66. The stock has a market capitalization of $6.33 billion, a PE ratio of 25.19 and a beta of 0.89.
Dolby Laboratories (NYSE:DLB – Get Free Report) last posted its quarterly earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.70 by $0.29. Dolby Laboratories had a net margin of 18.90% and a return on equity of 11.99%. The business had revenue of $307.02 million during the quarter, compared to the consensus estimate of $305.76 million. During the same period in the previous year, the firm posted $0.61 earnings per share. Dolby Laboratories’s revenue for the quarter was up .7% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. As a group, equities analysts expect that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.
Dolby Laboratories Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Shareholders of record on Tuesday, December 2nd were issued a dividend of $0.36 per share. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.33. This represents a $1.44 annualized dividend and a yield of 2.2%. The ex-dividend date was Tuesday, December 2nd. Dolby Laboratories’s dividend payout ratio is presently 54.75%.
About Dolby Laboratories
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Further Reading
- Five stocks we like better than Dolby Laboratories
- Wall Street Stock picker Names #1 Stock of 2026
- Do not delete, read immediately
- They Laughed at $30. They Won’t Laugh at $70.
- How Long Will $1M Last in Retirement?
- “$6.6 Trillion Of Customer Bank Deposits At Risk”
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
